Evidence map›Paper›PMID 38952865›Full record

ArticleFrontiers in medicine2024

Changes in primary care visits for respiratory illness during the COVID-19 pandemic: a multinational study by the International Consortium of Primary Care Big Data Researchers (INTRePID).

John M Westfall, Angela Ortigoza Bonilla, María C Lapadula, Paula L Zingoni, William C W Wong, Knut A Wensaas, Wilson D Pace, Javier Silva-Valencia, Luciano F Scattini, Amy P P Ng and 15 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

John M WestfallDARTNet Institute, Aurora, CO, United States.
Angela Ortigoza BonillaDepartment of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
María C LapadulaDepartment of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
Paula L ZingoniMinistry of Health of the Autonomous City of Buenos Aires, Buenos Aires, Argentina.
William C W WongDepartment of Family Medicine and Primary Care, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Knut A WensaasResearch Unit for General Practice, NORCE Norwegian Research Centre AS, Bergen, Norway.
Wilson D PaceDARTNet Institute, Aurora, CO, United States.
Javier Silva-ValenciaCenter for Research in Primary Health Care (CINAPS), Universidad Peruana Cayetano Heredia, Lima, Peru.
Luciano F ScattiniMinistry of Health of the Autonomous City of Buenos Aires, Buenos Aires, Argentina.
Amy P P NgDepartment of Family Medicine and Primary Care, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Jo-Anne Manski-NankervisDepartment of General Practice and Primary Care, The University of Melbourne, Melbourne, VIC, Australia.
Zheng J LingDivision of Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Zhuo LiDepartment of Family Medicine and Primary Care, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Adrian H HealdSchool of Medical Sciences, Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, United Kingdom.
Adrian LaughlinDepartment of General Practice and Primary Care, The University of Melbourne, Melbourne, VIC, Australia.
Robert S KristianssonDepartment of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Christine M HallinanDepartment of General Practice and Primary Care, The University of Melbourne, Melbourne, VIC, Australia.
Lay H GohDivision of Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Gabriela GaonaDARTNet Institute, Aurora, CO, United States.
Signe FlottorpCentre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.
Simon de LusignanNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
María S Cuba-FuentesCenter for Research in Primary Health Care (CINAPS), Universidad Peruana Cayetano Heredia, Lima, Peru.
Valborg BasteNational Centre for Emergency Primary Health Care, NORCE Norwegian Research Centre, Bergen, Norway.
Karen TuDepartment of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
INTRePID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The majority of patients with respiratory illness are seen in primary care settings. Given COVID-19 is predominantly a respiratory illness, the INTernational ConsoRtium of Primary Care BIg Data Researchers (INTRePID), assessed the pandemic impact on primary care visits for respiratory illnesses. Design: Definitions for respiratory illness types were agreed on collectively. Monthly visit counts with diagnosis were shared centrally for analysis. Setting: Primary care settings in Argentina, Australia, Canada, China, Norway, Peru, Singapore, Sweden and the United States. Participants: Over 38 million patients seen in primary care settings in INTRePID countries before and during the pandemic, from January 1st, 2018, to December 31st, 2021. Main outcome measures: Relative change in the monthly mean number of visits before and after the onset of the pandemic for acute infectious respiratory disease visits including influenza, upper and lower respiratory tract infections and chronic respiratory disease visits including asthma, chronic obstructive pulmonary disease, respiratory allergies, and other respiratory diseases. Results: INTRePID countries reported a marked decrease in the average monthly visits for respiratory illness. Changes in visits varied from -10.9% [95% confidence interval (CI): -33.1 to +11.3%] in Norway to -79.9% (95% CI: -86.4% to -73.4%) in China for acute infectious respiratory disease visits and - 2.1% (95% CI: -12.1 to +7.8%) in Peru to -59.9% (95% CI: -68.6% to -51.3%) in China for chronic respiratory illness visits. While seasonal variation in allergic respiratory illness continued during the pandemic, there was essentially no spike in influenza illness during the first 2 years of the pandemic. Conclusion: The COVID-19 pandemic had a major impact on primary care visits for respiratory presentations. Primary care continued to provide services for respiratory illness, although there was a decrease in infectious illness during the COVID pandemic. Understanding the role of primary care may provide valuable information for COVID-19 recovery efforts and planning for future global emergencies.

Indexed as

acute respiratory illnessasthmachronic respiratory illnessCOPDCOVID-19international comparisonprimary carereason for visit

Identifiers

PMID38952865
PMCPMC11215147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.